mifepristone has been researched along with 3,4-dihydroxyphenylacetic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Pan, JT; Yen, SH | 1 |
| Copeland, BJ; Hadjiconstantinou, M; Neff, NH | 1 |
| Kadotomi, Y; Kang, Z; Li, X; Song, C | 1 |
| Bregonzio, C; Deis, RP; Penissi, A; Soaje, M; Valdez, S | 1 |
| Bähr, M; Cheng, S; Déglon, N; Konstantinova, P; Kügler, S; Liefhebber, J; Mazur, A; Pythoud, C; Raina, A; Rey, M; Streit, F; Tereshchenko, J; Vachey, G; Zimmer, V | 1 |
7 other study(ies) available for mifepristone and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Progesterone advances the diurnal rhythm of tuberoinfundibular dopaminergic neuronal activity and the prolactin surge in ovariectomized, estrogen-primed rats and in intact proestrous rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arcuate Nucleus of Hypothalamus; Circadian Rhythm; Dopamine; Estradiol; Female; Hypothalamus; Median Eminence; Mifepristone; Neurons; Ovariectomy; Proestrus; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Progesterone; RNA, Antisense; Tuber Cinereum | 1998 |
Enhanced dopamine uptake in the striatum following repeated restraint stress.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenalectomy; Animals; Behavior, Animal; Biogenic Amines; Chromatography, High Pressure Liquid; Corpus Striatum; Corticosterone; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Electrochemistry; Haloperidol; Hormone Antagonists; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mifepristone; Nerve Tissue Proteins; Protein Binding; Quinpirole; Restraint, Physical; RNA, Messenger; Stress, Physiological; Time Factors; Tritium; Tyrosine | 2005 |
Omega-3 fatty acid ethyl-eicosapentaenoate attenuates IL-1beta-induced changes in dopamine and metabolites in the shell of the nucleus accumbens: involved with PLA2 activity and corticosterone secretion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Body Weight; Corticosterone; Dinoprostone; Dopamine; Drug Interactions; Eicosapentaenoic Acid; Homovanillic Acid; Hormone Antagonists; Interleukin-1beta; Male; Mifepristone; Nucleus Accumbens; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley | 2007 |
Dopaminergic mechanisms involved in prolactin release after mifepristone and naloxone treatment during late pregnancy in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Enzyme Inhibitors; Female; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Hormone Antagonists; Hydrazines; Hypothalamus; Mifepristone; Naloxone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2006 |
Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free "GeneSwitch" vector.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Disease Models, Animal; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Green Fluorescent Proteins; Homovanillic Acid; Hormone Antagonists; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Mifepristone; Oxidopamine; Parkinson Disease; Synapsins; Synucleins; Transduction, Genetic | 2018 |